Stocks and Investing Stocks and Investing
Mon, October 7, 2024

Mayank Mamtani Reiterated (TRVI) at Strong Buy and Held Target at $6 on, Oct 7th, 2024


Published on 2024-10-28 14:40:48 - WOPRAI, Mayank Mamtani
  Print publication without navigation


Mayank Mamtani of B. Riley Securities, Reiterated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $6 on, Oct 7th, 2024.

Mayank has made no other calls on TRVI in the last 4 months.



There are 6 other peers that have a rating on TRVI. Out of the 6 peers that are also analyzing TRVI, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Mayank


  • Jason Kolbert of "EF Hutton" Maintained at Strong Buy and Held Target at $21 on, Friday, October 4th, 2024
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $8 on, Friday, October 4th, 2024
  • Faisal Khurshid of "Leerink Partners" Initiated at Buy and Held Target at $7 on, Monday, September 9th, 2024
  • Oren Livnat of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $6 on, Friday, August 30th, 2024
  • Ryan Deschner of "Raymond James" Initiated at Buy and Held Target at $9 on, Friday, August 30th, 2024
  • Brandon Folkes of "Rodman & Renshaw" Initiated at Strong Buy and Held Target at $7 on, Thursday, June 13th, 2024
Contributing Sources